Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.
Ontology highlight
ABSTRACT: Despite recent advance of therapeutic development, coronary artery disease (CAD) remains one of the major issues to public health. The use of genomics and systems biology approaches to inform drug discovery and development have offered the possibilities for new target identification and in silico drug repurposing. In this study, we propose a network-based, systems pharmacology framework for target identification and drug repurposing in pharmacologic treatment and chemoprevention of CAD. Specifically, we build in silico models by integrating known drug-target interactions, CAD genes derived from the genetic and genomic studies, and the human protein-protein interactome. We demonstrate that the proposed in silico models can successfully uncover approved drugs and novel natural products in po
SUBMITTER: Fang J
PROVIDER: S-EPMC6263141 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA